The Echo Chamber: Part Five

In the last article, we followed some of the money through historic tax credits, LLCs, syndicators, and public incentive policy.

But the Echo Chamber does not stop at real estate.

The next room is healthcare.

Rep. Michael Echols is currently carrying House Bill 919, a bill dealing with pharmacy benefit managers, or PBMs.

In plain English, PBMs are the middlemen between insurance plans, drug manufacturers, and pharmacies. HB 919 would require PBMs to reimburse independent pharmacies under certain minimum standards, including protections against under-reimbursement and added transparency requirements. The Louisiana Legislature currently lists HB 919 as pending in the Senate Insurance Committee after being considered on April 28, 2026.

On its face, that may sound like ordinary pharmacy legislation.

But in Echols’s case, the public record raises a much more specific question:

What happens when the lawmaker writing pharmacy reimbursement policy has family and financial history tied directly to the healthcare and pharmacy world affected by that policy?

According to Echols’s own sworn personal financial disclosures, he worked for Vantage Health Plan as Director of Business Development. In his 2018 filing, he described his job as:

“Recruit physicians for Affinity and Brand Management for Vantage.”

Affinity Health Group was not some random medical company.

It was tied directly to Vantage Health Plan, the company founded by Dr. Jones, Echols’s father-in-law. A 2013 ULM release identified Dr. Gary Jones as CEO of Affinity Health Group, and public reporting later confirmed Affinity transitioned to The Baton Rouge Clinic, effective October 1, 2024.

So the documented record shows this:

Echols worked in the healthcare network.

His job involved building Affinity’s physician network.

Affinity operated under the Vantage umbrella.

Vantage was founded by his father-in-law.

His campaign received contributions from the Jones household and an in-kind fundraiser contribution from Vantage.

And now Echols is carrying legislation that affects pharmacy reimbursement economics.

While that chain doesn’t prove wrongdoing, it absolutely raises a disclosure question.

Because Affinity was not only a physician network. It also operated pharmacy locations. And pharmacy reimbursement is exactly the arena HB 919 touches.

And the medical web does not stop with his father-in-law.

It also reaches into the Myrick side of the family.

Ronnie Myrick, Echols’s stepfather, is tied to a network of nursing home and healthcare entities. Nursing homes depend heavily on pharmacy services, Medicaid, Medicare, and reimbursement structures. PBM legislation can affect the economics of pharmacy services connected to long-term care.

That means both family branches, Jones through Vantage and Affinity, and Myrick through nursing homes and healthcare operations, sit inside industries shaped by reimbursement policy.

Again, the records do not prove that HB 919 was written to benefit any specific family member or company.

But they do show a pattern that deserves public scrutiny:

Echols’s private world keeps overlapping with the public policies he carries.

In real estate, it was tax credits.

In healthcare, it is reimbursement.

Different industry.

Same echo.

And as the web becomes increasingly intertwined, the echoes grow louder.

The trend doesn’t stop here. See you soon.